North America Brain Health Supplements Market Outlook to 2030: Size, Share, Growth and Trends

North America Brain Health Supplements Market is valued at USD 4,270 Mn in 2024. This is based on manufacturer and brand-owner revenue, using retail sales value adjusted to an ex-factory equivalent rather than gross marketplace turnover. The market also moved 1,310 million units in 2024, which confirms that the category has already reached mass-consumption scale across memory, focus, mood, and sleep-adjacent formulations. For decision-makers, the more important point is that the market is no longer an experimental nootropics niche; it is now a structured supplement category with multiple monetizable sub-pools and recurring purchase behavior.

The market is projected to reach USD 7,750 Mn by 2030, implying a 10.4% CAGR for 2025-2030. Growth is expected to outpace the historical 8.0% CAGR during 2019-2024, which indicates a clear acceleration rather than simple continuation. The forecast assumes stronger premiumization, greater adoption of combination formulas, and faster scaling of adaptogens and mushroom-based products. In practical terms, revenue growth is expected to run ahead of pure unit growth because the category is moving toward higher-priced formulations with stronger brand narratives and better direct-to-consumer economics.

The profit pool is shifting away from standalone commodity formats and toward faster-growing, higher-ASP categories. In 2024, Herbal Extracts remained the largest segment at 27.5% of market value, but Adaptogens & Mushroom-Based Supplements are expanding faster at 16.2% CAGR. Combination / Proprietary Stack Formulas are still only 3.0% of 2024 value, yet they carry disproportionate strategic importance because they support stronger branding, recurring subscriptions, and ingredient-level differentiation. This means future value capture will be determined less by category presence and more by who controls complex formulations, claims architecture, and consumer education.

The largest operating risk is not demand volatility; it is regulatory and quality execution failure. The market spans three different compliance environments, with U.S. post-market enforcement, Canadian pre-market licensing, and Mexican advertising controls. This creates direct risk around claims language, ingredient eligibility, label architecture, and supply-chain quality. A brand can grow quickly on digital channels but still face sharp commercial disruption if its formulation, disclaimer placement, or quality documentation does not translate cleanly across jurisdictions. This is especially important for nootropic blends and novel ingredients, where scientific nuance and regulatory interpretation matter more than marketing intensity.

Demand is heavily concentrated in the United States. Internal regional allocation places the country at roughly 79% of North America revenue in 2024, supported by its deeper supplement ecosystem, higher older-adult population, and broader omnichannel distribution scale. Canada contributes a smaller but attractive regulated market, while Mexico remains a lower-base but faster-growing challenger opportunity. For companies, this means the region should not be approached as one uniform market. The United States typically justifies brand-building investment first, whereas Canada and Mexico require more selective localization around filings, claims, and channel economics.

The primary structural driver is the convergence of broad supplement familiarity with cognitive need states linked to aging, sleep, and daily performance. U.S. adults already show high supplement participation, and official public-health data indicate persistent short-sleep and sleep-difficulty prevalence. That creates a commercially attractive overlap between existing wellness buyers and consumers seeking help with memory, focus, calm, or sleep quality. The market therefore benefits from behavioral adjacency rather than having to create entirely new demand. This is why cognition-positioned products can scale quickly when they are framed within established supplement routines and supported by credible ingredient stories.